BackIovance Biotherapeutics Overview
Iovance Biotherapeutics Inc

Iovance Biotherapeutics Target Price

Analysts' 12-month price predictions for IOVA.

Share Price

$5.56

Average Target Price

$12.25120.3% upside

2 analysts in the last 4 months

High: $17 | Low: $7.5

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2025-01-31Piper SandlerJoseph Catanzaro$7.534.9% upsideOpen
2024-10-24UBSDavid Dai$17205.8% upsideOpen
2024-08-09Stifel NicolausBenjamin Burnett$11.5106.8% upsideOpen
2024-08-09Robert W. BairdColleen Kusy$12115.8% upsideOpen
2024-07-29Piper SandlerJoseph Catanzaro$1079.9% upsideOpen
2024-06-20JMP SecuritiesReni Benjamin$11.5106.8% upsideOpen
2024-05-31Stifel NicolausBenjamin Burnett$14151.8% upsideOpen
2024-03-14Piper SandlerJoseph Catanzaro$19241.7% upsideOpen
2022-12-08Goldman SachsMadhu Kumar$67.9% upsideOpen
2022-11-20Piper SandlerJoseph Catanzaro$1197.8% upsideOpen
2022-08-23Robert W. BairdMichael Ulz$12.5124.8% upsideOpen
2022-07-01Goldman Sachs$18223.7% upsideOpen
2022-05-27Stifel Nicolaus$13133.8% upsideOpen
2022-04-07Robert W. BairdColleen Kusy$34511.5% upsideOpen
2022-04-05Robert W. BairdColleen M. Kusy$30439.6% upsideOpen
2022-01-28Stifel NicolausBenjamin Burnett$25349.6% upsideOpen
2022-01-05Wells FargoNick Abbott$25349.6% upsideOpen
2021-05-19BarclaysPeter Lawson$40619.4% upsideOpen